Yayın:
Evaluation of biomechanical properties of the cornea in patients with primary hyperparathyroidism

dc.contributor.authorÇankaya, Ali Bülent
dc.contributor.authorKan, Seyfullah
dc.contributor.authorKizilgul, Muhammed
dc.contributor.authorTokmak, Aslı
dc.contributor.authorInanc, Merve
dc.contributor.authorCaliskan, Mustafa
dc.contributor.authorBeyazyildiz, Emrullah
dc.contributor.authorAçar, Ugur
dc.contributor.authorDelibaşı, Tuncay
dc.date.accessioned2026-01-02T23:43:35Z
dc.date.issued2016-07-16
dc.description.abstractThe purpose of this study is to compare the corneal biomechanical properties in primary hyperparathyroid patients and healthy control subjects. The study consisted of 31 patients with primary hyperparathyroidism (study group) and 31 healthy subjects (control group). Corneal biomechanical properties, including corneal hysteresis (CH), corneal resistance factor (CRF), and intraocular pressure (IOP) were measured with an ocular response analyzer (ORA). IOP was also measured using Goldmann applanation tonometry (GAT), and central corneal thickness (CCT) was measured with an ultrasonic pachymeter. The differences in ORA parameters and CCT between study and control group participants were analyzed. The mean CH in study and control groups was 8.7 ± 1.9 mmHg (5.3-13.7 mmHg) and 9.8 ± 1.5 mmHg (7.7-14.3 mmHg), respectively (p = 0.018). The mean CRF was 9.5 ± 1.8 (5.5-13.7) in the study group compared with 9.8 ± 1.5 (6.2-12.8) in the control group. The difference for CRF was not statistically significant (p = 0.41). In study and control group, corneal-compensated IOP (IOPcc) values were 18.2 ± 4.2 and 16.9 ± 2.7 mmHg, respectively (p = 0.12). Mean IOP measurement values with GAT were 16.3 ± 3.4 mmHg for study group and 16.5 ± 2.7 mmHg for control group (p = 0.71). The mean differences of IOPcc and IOPGAT in the study group eyes were higher than that of control group eyes (1.9 vs. 0.4 mmHg). CCT was 536.5 ± 25.4 µm (490-593 µm) in study group eyes compared with 534.2 ± 31.4 µm (472-602 µm) in control eyes (p = 0.75). Hyperparathyroidism could be associated with a decrease of CH. The differences between IOPcc and IOPGAT in these patients were higher than normal subjects. Underestimation of IOP readings with GAT may be a consequence of the lower CH in patients with hyperparathyroididsm.
dc.description.urihttps://doi.org/10.1007/s10792-016-0292-6
dc.description.urihttps://pubmed.ncbi.nlm.nih.gov/27423457
dc.description.urihttps://dx.doi.org/10.1007/s10792-016-0292-6
dc.identifier.doi10.1007/s10792-016-0292-6
dc.identifier.eissn1573-2630
dc.identifier.endpage524
dc.identifier.issn0165-5701
dc.identifier.openairedoi_dedup___::c6934ee87d357ffb2960eade93193581
dc.identifier.orcid0000-0001-5239-3895
dc.identifier.pubmed27423457
dc.identifier.scopus2-s2.0-84978886828
dc.identifier.startpage519
dc.identifier.urihttps://hdl.handle.net/20.500.12597/36220
dc.identifier.volume37
dc.identifier.wos000401918500011
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.relation.ispartofInternational Ophthalmology
dc.rightsCLOSED
dc.subjectMale
dc.subjectVisual Acuity
dc.subjectMiddle Aged
dc.subjectHyperparathyroidism, Primary
dc.subjectPrognosis
dc.subjectElasticity
dc.subjectCorneal Diseases
dc.subjectCornea
dc.subjectCross-Sectional Studies
dc.subjectHumans
dc.subjectFemale
dc.subjectIntraocular Pressure
dc.subject.sdg3. Good health
dc.titleEvaluation of biomechanical properties of the cornea in patients with primary hyperparathyroidism
dc.typeArticle
dspace.entity.typePublication
local.api.response{"authors":[{"fullName":"Ali Bülent, Çankaya","name":"Ali Bülent","surname":"Çankaya","rank":1,"pid":null},{"fullName":"Seyfullah, Kan","name":"Seyfullah","surname":"Kan","rank":2,"pid":null},{"fullName":"Muhammed, Kizilgul","name":"Muhammed","surname":"Kizilgul","rank":3,"pid":null},{"fullName":"Aslı, Tokmak","name":"Aslı","surname":"Tokmak","rank":4,"pid":{"id":{"scheme":"orcid","value":"0000-0001-5239-3895"},"provenance":null}},{"fullName":"Merve, Inanc","name":"Merve","surname":"Inanc","rank":5,"pid":null},{"fullName":"Mustafa, Caliskan","name":"Mustafa","surname":"Caliskan","rank":6,"pid":null},{"fullName":"Emrullah, Beyazyildiz","name":"Emrullah","surname":"Beyazyildiz","rank":7,"pid":null},{"fullName":"Ugur, Açar","name":"Ugur","surname":"Açar","rank":8,"pid":null},{"fullName":"Tuncay, Delibaşı","name":"Tuncay","surname":"Delibaşı","rank":9,"pid":null}],"openAccessColor":null,"publiclyFunded":false,"type":"publication","language":{"code":"eng","label":"English"},"countries":null,"subjects":[{"subject":{"scheme":"keyword","value":"Male"},"provenance":null},{"subject":{"scheme":"keyword","value":"Visual Acuity"},"provenance":null},{"subject":{"scheme":"keyword","value":"Middle Aged"},"provenance":null},{"subject":{"scheme":"keyword","value":"Hyperparathyroidism, Primary"},"provenance":null},{"subject":{"scheme":"keyword","value":"Prognosis"},"provenance":null},{"subject":{"scheme":"keyword","value":"Elasticity"},"provenance":null},{"subject":{"scheme":"keyword","value":"Corneal Diseases"},"provenance":null},{"subject":{"scheme":"SDG","value":"3. Good health"},"provenance":null},{"subject":{"scheme":"keyword","value":"Cornea"},"provenance":null},{"subject":{"scheme":"FOS","value":"03 medical and health sciences"},"provenance":null},{"subject":{"scheme":"keyword","value":"Cross-Sectional Studies"},"provenance":null},{"subject":{"scheme":"FOS","value":"0302 clinical medicine"},"provenance":null},{"subject":{"scheme":"keyword","value":"Humans"},"provenance":null},{"subject":{"scheme":"keyword","value":"Female"},"provenance":null},{"subject":{"scheme":"keyword","value":"Intraocular Pressure"},"provenance":null}],"mainTitle":"Evaluation of biomechanical properties of the cornea in patients with primary hyperparathyroidism","subTitle":null,"descriptions":["The purpose of this study is to compare the corneal biomechanical properties in primary hyperparathyroid patients and healthy control subjects. The study consisted of 31 patients with primary hyperparathyroidism (study group) and 31 healthy subjects (control group). Corneal biomechanical properties, including corneal hysteresis (CH), corneal resistance factor (CRF), and intraocular pressure (IOP) were measured with an ocular response analyzer (ORA). IOP was also measured using Goldmann applanation tonometry (GAT), and central corneal thickness (CCT) was measured with an ultrasonic pachymeter. The differences in ORA parameters and CCT between study and control group participants were analyzed. The mean CH in study and control groups was 8.7 ± 1.9 mmHg (5.3-13.7 mmHg) and 9.8 ± 1.5 mmHg (7.7-14.3 mmHg), respectively (p = 0.018). The mean CRF was 9.5 ± 1.8 (5.5-13.7) in the study group compared with 9.8 ± 1.5 (6.2-12.8) in the control group. The difference for CRF was not statistically significant (p = 0.41). In study and control group, corneal-compensated IOP (IOPcc) values were 18.2 ± 4.2 and 16.9 ± 2.7 mmHg, respectively (p = 0.12). Mean IOP measurement values with GAT were 16.3 ± 3.4 mmHg for study group and 16.5 ± 2.7 mmHg for control group (p = 0.71). The mean differences of IOPcc and IOPGAT in the study group eyes were higher than that of control group eyes (1.9 vs. 0.4 mmHg). CCT was 536.5 ± 25.4 µm (490-593 µm) in study group eyes compared with 534.2 ± 31.4 µm (472-602 µm) in control eyes (p = 0.75). Hyperparathyroidism could be associated with a decrease of CH. The differences between IOPcc and IOPGAT in these patients were higher than normal subjects. Underestimation of IOP readings with GAT may be a consequence of the lower CH in patients with hyperparathyroididsm."],"publicationDate":"2016-07-16","publisher":"Springer Science and Business Media LLC","embargoEndDate":null,"sources":["Crossref"],"formats":null,"contributors":null,"coverages":null,"bestAccessRight":{"code":"c_14cb","label":"CLOSED","scheme":"http://vocabularies.coar-repositories.org/documentation/access_rights/"},"container":{"name":"International Ophthalmology","issnPrinted":"0165-5701","issnOnline":"1573-2630","issnLinking":null,"ep":"524","iss":null,"sp":"519","vol":"37","edition":null,"conferencePlace":null,"conferenceDate":null},"documentationUrls":null,"codeRepositoryUrl":null,"programmingLanguage":null,"contactPeople":null,"contactGroups":null,"tools":null,"size":null,"version":null,"geoLocations":null,"id":"doi_dedup___::c6934ee87d357ffb2960eade93193581","originalIds":["292","10.1007/s10792-016-0292-6","50|doiboost____|c6934ee87d357ffb2960eade93193581","27423457","2467576511"],"pids":[{"scheme":"doi","value":"10.1007/s10792-016-0292-6"},{"scheme":"pmid","value":"27423457"}],"dateOfCollection":null,"lastUpdateTimeStamp":null,"indicators":{"citationImpact":{"citationCount":0,"influence":2.5349236e-9,"popularity":8.410903e-10,"impulse":0,"citationClass":"C5","influenceClass":"C5","impulseClass":"C5","popularityClass":"C5"}},"instances":[{"pids":[{"scheme":"doi","value":"10.1007/s10792-016-0292-6"}],"license":"Springer TDM","type":"Article","urls":["https://doi.org/10.1007/s10792-016-0292-6"],"publicationDate":"2016-07-16","refereed":"peerReviewed"},{"pids":[{"scheme":"pmid","value":"27423457"}],"alternateIdentifiers":[{"scheme":"doi","value":"10.1007/s10792-016-0292-6"}],"type":"Article","urls":["https://pubmed.ncbi.nlm.nih.gov/27423457"],"publicationDate":"2017-09-19","refereed":"nonPeerReviewed"},{"alternateIdentifiers":[{"scheme":"mag_id","value":"2467576511"},{"scheme":"doi","value":"10.1007/s10792-016-0292-6"}],"type":"Article","urls":["https://dx.doi.org/10.1007/s10792-016-0292-6"],"refereed":"nonPeerReviewed"}],"isGreen":false,"isInDiamondJournal":false}
local.import.sourceOpenAire
local.indexed.atWOS
local.indexed.atScopus
local.indexed.atPubMed

Dosyalar

Koleksiyonlar